002030 達安基因
按盤價 
6.870 -0.760 (-9.961%)
6.870 -0.760 (-9.961%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.812 | -11.040 | 1.037 | 58.034 | 62.275 |
| 總資產報酬率 ROA (%) | -1.516 | -8.984 | 0.812 | 43.137 | 42.476 |
| 投入資產回報率 ROIC (%) | -1.739 | -10.492 | 0.991 | 54.967 | 55.868 | 邊際利潤分析 |
| 銷售毛利率 (%) | 32.667 | 37.547 | 50.467 | 72.842 | 74.765 |
| 營業利潤率 (%) | -32.850 | -125.155 | 10.299 | 52.542 | 53.826 |
| 息稅前利潤/營業總收入 (%) | -39.559 | -133.200 | 3.285 | 51.534 | 53.355 |
| 淨利潤/營業總收入 (%) | -29.945 | -110.092 | 6.074 | 45.056 | 47.212 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 128.049 | 19.142 | 41.799 | 108.478 | 98.636 |
| 價值變動淨收益/利潤總額(%) | -118.866 | 40.104 | 360.629 | 5.594 | 3.285 |
| 營業外收支淨額/利潤總額(%) | 2.461 | 0.332 | -7.122 | -0.163 | -0.129 | 償債能力分析 |
| 流動比率 (X) | 3.059 | 2.923 | 3.085 | 2.954 | 2.374 |
| 速動比率 (X) | 2.852 | 2.770 | 2.946 | 2.829 | 2.178 |
| 資產負債率 (%) | 12.088 | 14.972 | 16.889 | 21.286 | 25.894 |
| 帶息債務/全部投入資本 (%) | 1.817 | 2.488 | 4.150 | 2.072 | 5.893 |
| 股東權益/帶息債務 (%) | 5,295.346 | 3,850.355 | 2,273.624 | 4,656.178 | 1,563.747 |
| 股東權益/負債合計 (%) | 704.168 | 549.549 | 477.214 | 359.775 | 274.665 |
| 利息保障倍數 (X) | 6.727 | 17.462 | -0.519 | -55.909 | -132.714 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 555.223 | 698.914 | 933.398 | 94.518 | 88.190 |
| 存貨周轉天數 (天) | 156.212 | 147.901 | 187.444 | 47.499 | 75.332 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 29/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
